Biomarker guidance allows a more personalized allocation of patients for remote patient management in heart failure: results from the TIM‐HF2 trial-Reference-Cited by-同舟云学术

Biomarker guidance allows a more personalized allocation of patients for remote patient management in heart failure: results from the TIM‐HF2 trial

Published:2019-06-17 Issue:11 Volume:21 Page:1445-1458
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Möckel Martin¹,Koehler Kerstin²,Anker Stefan D.³,Vollert Jörn⁴,Moeller Volker²,Koehler Magdalena⁵,Gehrig Stefan⁴,Wiemer Jan C.⁴,Haehling Stephan⁶,Koehler Friedrich²

Affiliation:

1. Division of Emergency and Acute Medicine, Cardiovascular Process ResearchCampus Mitte and Virchow, Charité ‐ Universitätsmedizin Berlin Berlin Germany

2. Centre for Cardiovascular Telemedicine, Department of Cardiology and AngiologyCampus Mitte, Charité – Universitätsmedizin Berlin Berlin Germany

3. Department of Cardiology (CVK) and Berlin Institute of Health, Center for Regenerative Therapies (BCRT)German Centre for Cardiovascular Research (DZHK) partner site Berlin Charité ‐ Universitätsmedizin Berlin Berlin Germany

4. Clinical Diagnostics, Thermo Fisher Scientific Hennigsdorf Germany

5. Technical University Munich, Department of Prevention, Rehabilitation and Sports MedicineLudwig‐Maximilians‐Universität Munich Germany

6. Department of Cardiology and PneumologyUniversitätsmedizin Göttingen Göttingen Germany

Funder

Thermo Fisher Scientific

Haridus- ja Teadusministeerium

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1530